[Federal Register Volume 69, Number 133 (Tuesday, July 13, 2004)]
[Notices]
[Page 42058]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-15795]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control; Special 
Emphasis Panel (SEP): Monitoring Atypical HIV Strains Among Persons 
Newly Diagnosed With HIV Using Blood Spots vs. Diagnostic Sera, Program 
Announcement Number 04118

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Monitoring Atypical HIV Strains Among 
Persons Newly Diagnosed with HIV Using Blood Spots vs. Diagnostic 
Sera, Program Announcement Number 04118.
    Times and Dates: 8:30 a.m.-9:15 a.m., August 3, 2004 (open), 
9:15 a.m.-4:15 p.m., August 3, 2004 (closed).
    Place: The Westin Buckhead Atlanta, 3391 Peachtree Road, NE., 
Atlanta, GA 30326, Telephone Number (404) 365-0065.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Special Emphasis Panel (SEP): Monitoring Atypical HIV Strains Among 
Persons Newly Diagnosed with HIV Using Blood Spots vs. Diagnostic 
Sera, Program Announcement Number 04118.
    For Further Information Contact: Noreen L. Qualls, DrPH, 
Scientific Review Administrator, Centers for Disease Control, 
National Center for HIV, STD, Office of the Associate Director for 
Science, 1600 Clifton Road NE., Mailstop E07, Atlanta, GA 30333, 
Telephone (404) 639-8006.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 29, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-15795 Filed 7-12-04; 8:45 am]
BILLING CODE 4163-18-P